127 related articles for article (PubMed ID: 38524109)
81. HPV Cotesting of Unsatisfactory Papanicolaou Tests: Implications for Follow-up Intervals.
Chen F; Hsu Lin L; Hindi I; Sun W; Shafizadeh N; Szeto O; Brandler TC; Simsir A
Am J Clin Pathol; 2023 Aug; 160(2):137-143. PubMed ID: 37052613
[TBL] [Abstract][Full Text] [Related]
82. Screening for cervical carcinoma using visual inspection with acetic acid.
Abdel-Hady ES; Emam M; Al-Gohary A; Hassan M; Farag MK; Abo-Elkheir M
Int J Gynaecol Obstet; 2006 May; 93(2):118-22. PubMed ID: 16549069
[TBL] [Abstract][Full Text] [Related]
83. Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia.
Simms KT; Hall M; Smith MA; Lew JB; Hughes S; Yuill S; Hammond I; Saville M; Canfell K
PLoS One; 2017; 12(1):e0163509. PubMed ID: 28095411
[TBL] [Abstract][Full Text] [Related]
84. Screening of Cervical Cancer: Visual Inspection with Acetic Acid (VIA) and Site of Lesion Verified by Multiple Punch Biopsies.
Gad MM; Galal SB; Helmy W; Abd El-Fattah NH
Folia Med (Plovdiv); 2019 Jun; 61(2):289-295. PubMed ID: 31301660
[TBL] [Abstract][Full Text] [Related]
85. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
Mandelblatt JS; Lawrence WF; Gaffikin L; Limpahayom KK; Lumbiganon P; Warakamin S; King J; Yi B; Ringers P; Blumenthal PD
J Natl Cancer Inst; 2002 Oct; 94(19):1469-83. PubMed ID: 12359856
[TBL] [Abstract][Full Text] [Related]
86. A pilot study of low-cost, high-resolution microendoscopy as a tool for identifying women with cervical precancer.
Pierce MC; Guan Y; Quinn MK; Zhang X; Zhang WH; Qiao YL; Castle P; Richards-Kortum R
Cancer Prev Res (Phila); 2012 Nov; 5(11):1273-9. PubMed ID: 22926339
[TBL] [Abstract][Full Text] [Related]
87. Cervical Screening by Pap Test and Visual Inspection Enabling Same-Day Biopsy in Low-Resource, High-Risk Communities.
Tao L; Amanguli A; Li F; Wang YH; Yang L; Mohemaiti M; Zhao J; Zou XG; Saimaiti A; Abudu M; Maimaiti M; Chen SY; Abudukelimu R; Maimaiti A; Li SG; Zhang W; Aizimu A; Yang AQ; Wang J; Pang LJ; Cao YG; Gu WY; Zhang WJ
Obstet Gynecol; 2018 Dec; 132(6):1421-1429. PubMed ID: 30399093
[TBL] [Abstract][Full Text] [Related]
88. Clinical Evaluation of Human Papillomavirus Screening With p16/Ki-67 Dual Stain Triage in a Large Organized Cervical Cancer Screening Program.
Wentzensen N; Clarke MA; Bremer R; Poitras N; Tokugawa D; Goldhoff PE; Castle PE; Schiffman M; Kingery JD; Grewal KK; Locke A; Kinney W; Lorey TS
JAMA Intern Med; 2019 Jul; 179(7):881-888. PubMed ID: 31081870
[TBL] [Abstract][Full Text] [Related]
89. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial.
Denny L; Kuhn L; De Souza M; Pollack AE; Dupree W; Wright TC
JAMA; 2005 Nov; 294(17):2173-81. PubMed ID: 16264158
[TBL] [Abstract][Full Text] [Related]
90. [Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].
Dumont A; Bessières N; Benbassa A; Razafindrafara G; Rabearison F; Philippe HJ
J Gynecol Obstet Hum Reprod; 2017 Apr; 46(4):327-332. PubMed ID: 28643659
[TBL] [Abstract][Full Text] [Related]
91. Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Ovando N; Calle P; Torrico A; Villarroel J; Bossens M; Fontaine V; Rodriguez P
BMC Infect Dis; 2020 Apr; 20(1):259. PubMed ID: 32245369
[TBL] [Abstract][Full Text] [Related]
92. Smartphone Use for Cervical Cancer Screening in Low-Resource Countries: A Pilot Study Conducted in Madagascar.
Catarino R; Vassilakos P; Scaringella S; Undurraga-Malinverno M; Meyer-Hamme U; Ricard-Gauthier D; Matute JC; Petignat P
PLoS One; 2015; 10(7):e0134309. PubMed ID: 26222772
[TBL] [Abstract][Full Text] [Related]
93. Naked-eye inspection of the cervix after acetic acid application may improve the predictive value of negative cytologic screening.
Frisch LE; Milner FH; Ferris DG
J Fam Pract; 1994 Nov; 39(5):457-60. PubMed ID: 7755697
[TBL] [Abstract][Full Text] [Related]
94. Early detection of precursors of cervical cancer with cervical cytology and visual inspection of cervix with acetic Acid.
Dhaubhadel P; Vaidya A; Choudhary P
JNMA J Nepal Med Assoc; 2008; 47(170):71-6. PubMed ID: 18709035
[TBL] [Abstract][Full Text] [Related]
95. Cervical Cancer Screening: A Review.
Perkins RB; Wentzensen N; Guido RS; Schiffman M
JAMA; 2023 Aug; 330(6):547-558. PubMed ID: 37552298
[TBL] [Abstract][Full Text] [Related]
96. Post-colposcopy Management of ASC-US and LSIL Pap Tests (PALS Trial): Pilot RCT.
Saciragic L; Nelson G; Chiarella-Redfern H; Kanarek N; Nation J; Duggan MA
J Obstet Gynaecol Can; 2019 Jul; 41(7):916-925. PubMed ID: 31230661
[TBL] [Abstract][Full Text] [Related]
97. Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy.
Bhattachan K; Dangal G; Karki A; Pradhan HK; Shrestha R; Parajuli S; Poudel R; Bajracharya N; Tiwari K
J Nepal Health Res Counc; 2019 Apr; 17(1):76-79. PubMed ID: 31110381
[TBL] [Abstract][Full Text] [Related]
98. HPV detection in a self-collected vaginal swab combined with VIA for cervical cancer screening with correlation to histologically confirmed CIN.
Kamal EM; El Sayed GA; El Behery MM; El Shennawy GA
Arch Gynecol Obstet; 2014 Dec; 290(6):1207-13. PubMed ID: 25009070
[TBL] [Abstract][Full Text] [Related]
99. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
[TBL] [Abstract][Full Text] [Related]
100. [The timeline of the screening and treatment strategy of intraepithelial neoplasia of the uterine cervix adopted in Morocco].
Zraidi M; Ibriz M
Pan Afr Med J; 2024; 47():13. PubMed ID: 38524109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
